...
首页> 外文期刊>Spectroscopy >Ultrasensitive determination for picomolar-level midecamycin in human serum by flow injection chemiluminescence using luminol–BSA system
【24h】

Ultrasensitive determination for picomolar-level midecamycin in human serum by flow injection chemiluminescence using luminol–BSA system

机译:鲁米诺-BSA系统流动注射化学发光法超灵敏测定人血清中的皮摩尔水平的麦德霉素

获取原文
           

摘要

An ultrasensitive method for determining picomolar midecamycin (MID) by flow injection (FI) chemiluminescence (CL) was first described based on the inhibitory effect of MID on luminol–BSA reaction. It was found that the CL intensity decrements were linear with the logarithm of MID concentrations in the range of 1.0–5000 pmol · l–1with a detection limit as low as 0.3 pmol · l–1(3σ). The relative standard deviation of seven repetitive measurements for 10 pmol · l–1MID was 3.0%. At a flow rate of 2.0 ml · min–1, the whole analysis procedure including sampling and washing could be finished in 30 s, offering the sample efficiency of 120 h–1. This proposed method was successfully applied to determine MID in human serum samples with the recoveries from 96.0 to 110.0%. The CL mechanism of luminol–BSA–MID reaction was also given.
机译:基于流动注射(FI)化学发光(CL)的皮摩尔类美德霉素(MID)的超灵敏方法首次基于MID对鲁米诺-BSA反应的抑制作用进行了描述。发现CL强度的下降与MID浓度在1.0–5000 pmol·l-1的对数呈线性关系,检出限低至0.3 pmol·l-1(3σ)。 10 pmol·l-1MID的七个重复测量的相对标准偏差为3.0%。以2.0 ml·min-1的流速,整个分析过程(包括取样和洗涤)可以在30 s内完成,从而提供120 h–1的样品效率。该方法成功地用于测定人血清样品中的MID,回收率为96.0%至110.0%。还给出了鲁米诺–BSA–MID反应的CL机理。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号